Introduction
The management of SCLC has been recently improved and survival rates are 15-25% at 2 years among patients with limited stage and 0-3% among those with extensive disease. The median overall survival with the combination chemotherapy is 14 to 16 months for patients with limited disease and 8 to 11 months for those with extensive disease. Most controlled clinical trials of SCLC define...read
Introduction
The management of SCLC has been recently improved and survival rates are 15-25% at 2 years among patients with limited stage and 0-3% among those with extensive disease. The median overall survival with the combination chemotherapy is 14 to 16 months for patients with limited disease and 8 to 11 months for those with extensive disease. Most controlled clinical trials of SCLC define...
